UiPath, Inc. (NYSE:PATH – Get Free Report) CEO Daniel Dines sold 122,734 shares of UiPath stock in a transaction dated Friday, October 10th. The shares were sold at an average price of $18.37, for a total transaction of $2,254,623.58. Following the sale, the chief executive officer owned 490,936 shares of the company’s stock, valued at $9,018,494.32. The trade was a 20.00% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website.
Daniel Dines also recently made the following trade(s):
- On Wednesday, October 8th, Daniel Dines sold 122,734 shares of UiPath stock. The stock was sold at an average price of $14.89, for a total transaction of $1,827,509.26.
- On Monday, October 6th, Daniel Dines sold 122,733 shares of UiPath stock. The shares were sold at an average price of $14.24, for a total transaction of $1,747,717.92.
- On Wednesday, October 1st, Daniel Dines sold 122,733 shares of UiPath stock. The shares were sold at an average price of $13.33, for a total value of $1,636,030.89.
- On Monday, September 29th, Daniel Dines sold 122,733 shares of UiPath stock. The stock was sold at an average price of $12.33, for a total value of $1,513,297.89.
- On Friday, September 26th, Daniel Dines sold 122,733 shares of UiPath stock. The shares were sold at an average price of $12.08, for a total value of $1,482,614.64.
- On Wednesday, September 24th, Daniel Dines sold 122,733 shares of UiPath stock. The stock was sold at an average price of $12.44, for a total value of $1,526,798.52.
- On Monday, September 22nd, Daniel Dines sold 122,733 shares of UiPath stock. The shares were sold at an average price of $12.20, for a total value of $1,497,342.60.
- On Friday, September 19th, Daniel Dines sold 122,733 shares of UiPath stock. The shares were sold at an average price of $11.92, for a total value of $1,462,977.36.
- On Wednesday, September 17th, Daniel Dines sold 122,733 shares of UiPath stock. The stock was sold at an average price of $11.71, for a total transaction of $1,437,203.43.
- On Wednesday, September 10th, Daniel Dines sold 45,000 shares of UiPath stock. The shares were sold at an average price of $12.01, for a total transaction of $540,450.00.
UiPath Stock Performance
Shares of PATH opened at $17.04 on Monday. The company has a 50 day moving average price of $11.99 and a 200-day moving average price of $12.04. UiPath, Inc. has a fifty-two week low of $9.38 and a fifty-two week high of $18.74. The stock has a market capitalization of $9.05 billion, a PE ratio of 567.83, a PEG ratio of 6.31 and a beta of 1.07.
Institutional Trading of UiPath
Several large investors have recently bought and sold shares of PATH. GAMMA Investing LLC lifted its position in shares of UiPath by 48.0% during the second quarter. GAMMA Investing LLC now owns 2,989 shares of the company’s stock worth $38,000 after purchasing an additional 969 shares in the last quarter. Rockefeller Capital Management L.P. grew its holdings in shares of UiPath by 0.8% in the second quarter. Rockefeller Capital Management L.P. now owns 123,329 shares of the company’s stock valued at $1,579,000 after purchasing an additional 1,033 shares in the last quarter. Xponance Inc. increased its stake in UiPath by 2.0% during the 1st quarter. Xponance Inc. now owns 54,246 shares of the company’s stock worth $559,000 after buying an additional 1,054 shares during the period. State Board of Administration of Florida Retirement System lifted its holdings in UiPath by 0.4% during the 2nd quarter. State Board of Administration of Florida Retirement System now owns 313,946 shares of the company’s stock worth $4,019,000 after buying an additional 1,190 shares in the last quarter. Finally, Covestor Ltd boosted its position in UiPath by 13.1% in the 1st quarter. Covestor Ltd now owns 11,070 shares of the company’s stock valued at $114,000 after buying an additional 1,283 shares during the period. Hedge funds and other institutional investors own 62.50% of the company’s stock.
Wall Street Analysts Forecast Growth
A number of equities research analysts recently weighed in on PATH shares. Weiss Ratings reaffirmed a “sell (d)” rating on shares of UiPath in a research report on Wednesday, October 8th. Wall Street Zen upgraded shares of UiPath from a “buy” rating to a “strong-buy” rating in a report on Saturday, September 6th. DA Davidson initiated coverage on shares of UiPath in a research report on Friday, September 5th. They issued a “neutral” rating and a $12.00 price objective on the stock. Truist Financial decreased their target price on shares of UiPath from $13.00 to $12.00 and set a “hold” rating for the company in a research report on Friday, September 5th. Finally, BMO Capital Markets lifted their price target on shares of UiPath from $12.50 to $13.00 and gave the stock a “market perform” rating in a report on Thursday, October 2nd. One research analyst has rated the stock with a Strong Buy rating, two have given a Buy rating, twelve have given a Hold rating and three have assigned a Sell rating to the company’s stock. Based on data from MarketBeat.com, the stock has an average rating of “Hold” and a consensus price target of $13.21.
Read Our Latest Analysis on UiPath
About UiPath
UiPath Inc provides an end-to-end automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, the United Kingdom, the Netherlands, and internationally. The company offers a suite of interrelated software to build, manage, run, engage, measure, and govern automation within the organization.
Featured Stories
- Five stocks we like better than UiPath
- What is the S&P/TSX Index?
- Microsoft 365 Premium Marks the Next Phase of AI Monetization
- Using the MarketBeat Stock Split Calculator
- Could Target’s Week of Discounts Come Full Circle for Investors?
- Short Selling – The Pros and Cons
- 3 Reasons to Buy Sprouts Farmers Market Ahead of Earnings
Receive News & Ratings for UiPath Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UiPath and related companies with MarketBeat.com's FREE daily email newsletter.